Clinical Trial Update: S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer [NA]

View source ↗

Summary

A completed clinical trial evaluating high-dose cholecalciferol (vitamin D3) for prevention in premenopausal women at high risk for breast cancer due to BRCA1 o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Cholecalciferol (Vitamin D3)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: brca1 Mutation Carrier, brca2 Mutation Carrier | NA | Status: COMPLETED